{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:52:15Z","timestamp":1780447935054,"version":"3.54.1"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,5]]},"DOI":"10.4103\/0366-6999.157703","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T09:45:45Z","timestamp":1432633545000},"page":"1559-1560","source":"Crossref","is-referenced-by-count":14,"title":["Healing Effects of Omalizumab in a Patient with Cholinergic Urticaria Associated Severe Dyspeptic Complaints"],"prefix":"10.1097","volume":"128","author":[{"given":"Ali","family":"Kutlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpaslan","family":"Tanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1468-3083.2011.04017.x","article-title":"Cholinergic urticaria: Pathogenesis-based categorization and its treatment options","volume":"26","author":"Nakamizo","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-26-20210129","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1056\/NEJMct055184","article-title":"Omalizumab for asthma","volume":"354","author":"Strunk","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-26-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"R4-26-20210129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"R5-26-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2172-3-5","article-title":"Transcriptional response of human mast cells stimulated via the Fc (epsilon) RI and identification of mast cells as a source of IL-11","volume":"3","author":"Sayama","year":"2002","journal-title":"BMC Immunol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.157703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:34:39Z","timestamp":1623958479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201506050-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.157703","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}